Uncategorized
IRIS Registry gives clinicians comparative data for individual practices
LOS ANGELES — While still relatively young, the IRIS Registry is already yielding clinically useful information at a practice level, according to David W. Parke II, MD, CEO of the American Academy of Ophthalmology.“The promise of big data is that we’re going to be able to statistically look at uncommon indications for common procedures, comorbidities, subpopulations, therapeutic comparisons. The big thing is we can do this not in a clinical trial with a discrete, very rigid protocol, but with what happens in the real world,” Parke told colleagues at the (Read more...)